These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 27900663)

  • 21. Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis.
    Setsu N; Kohashi K; Endo M; Yamamoto H; Tamiya S; Takahashi Y; Yamada Y; Ishii T; Matsuda S; Yokoyama R; Iwamoto Y; Oda Y
    Int J Cancer; 2013 Jan; 132(1):109-15. PubMed ID: 22644781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
    Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D
    Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-138 inhibits proliferation of cervical cancer cells by targeting c-Met.
    Li B; Yang XX; Wang D; Ji HK
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1109-14. PubMed ID: 27049264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer.
    Migliore C; Martin V; Leoni VP; Restivo A; Atzori L; Petrelli A; Isella C; Zorcolo L; Sarotto I; Casula G; Comoglio PM; Columbano A; Giordano S
    Clin Cancer Res; 2012 Feb; 18(3):737-47. PubMed ID: 22179665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
    Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
    Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.
    Roland CL; May CD; Watson KL; Al Sannaa GA; Dineen SP; Feig R; Landers S; Ingram DR; Wang WL; Guadagnolo BA; Feig B; Hunt KK; Cormier JN; Lazar AJ; Torres KE
    Ann Surg Oncol; 2016 Jul; 23(7):2220-8. PubMed ID: 26847678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
    Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
    Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PDCD4/miR-21 pathway in medullary thyroid carcinoma.
    Pennelli G; Galuppini F; Barollo S; Cavedon E; Bertazza L; Fassan M; Guzzardo V; Pelizzo MR; Rugge M; Mian C
    Hum Pathol; 2015 Jan; 46(1):50-7. PubMed ID: 25316501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MET gene copy number alterations and expression of MET and hepatocyte growth factor are potential biomarkers in angiosarcomas and undifferentiated pleomorphic sarcomas.
    Schmitz K; Koeppen H; Binot E; Fassunke J; Künstlinger H; Ihle MA; Heydt C; Wardelmann E; Büttner R; Merkelbach-Bruse S; Rüschoff J; Schildhaus HU
    PLoS One; 2015; 10(4):e0120079. PubMed ID: 25844809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
    Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
    Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of miRNAs in rhabdomyosarcoma and malignant rhabdoid tumor.
    Armeanu-Ebinger S; Herrmann D; Bonin M; Leuschner I; Warmann SW; Fuchs J; Seitz G
    Exp Cell Res; 2012 Dec; 318(20):2567-77. PubMed ID: 23000453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study.
    Moura DS; Mondaza-Hernandez JL; Sanchez-Bustos P; Peña-Chilet M; Cordero-Varela JA; Lopez-Alvarez M; Carrillo-Garcia J; Martin-Ruiz M; Romero-Gonzalez P; Renshaw-Calderon M; Ramos R; Marcilla D; Alvarez-Alegret R; Agra-Pujol C; Izquierdo F; Ortega-Medina L; Martin-Davila F; Hernandez-Leon CN; Romagosa C; Salgado MAV; Lavernia J; Bagué S; Mayodormo-Aranda E; Alvarez R; Valverde C; Martinez-Trufero J; Castilla-Ramirez C; Gutierrez A; Dopazo J; Hindi N; Garcia-Foncillas J; Martin-Broto J
    Cell Mol Life Sci; 2024 May; 81(1):219. PubMed ID: 38758230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation.
    Reid JF; Sokolova V; Zoni E; Lampis A; Pizzamiglio S; Bertan C; Zanutto S; Perrone F; Camerini T; Gallino G; Verderio P; Leo E; Pilotti S; Gariboldi M; Pierotti MA
    Mol Cancer Res; 2012 Apr; 10(4):504-15. PubMed ID: 22343615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression.
    Xie J; Chen M; Zhou J; Mo MS; Zhu LH; Liu YP; Gui QJ; Zhang L; Li GQ
    Oncol Rep; 2014 Apr; 31(4):1715-22. PubMed ID: 24573489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas.
    Franchi A; Massi D; Santucci M
    Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic role of XTP1/DEPDC1B and SDP35/DEPDC1A in high grade soft-tissue sarcomas.
    Pollino S; Benassi MS; Pazzaglia L; Conti A; Bertani N; Righi A; Piccinni-Leopardi M; Picci P; Perris R
    Histol Histopathol; 2018 Jun; 33(6):597-608. PubMed ID: 29297565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathological evaluation of soft tissue sarcoma for diagnosis, prognosis and treatment].
    Yamaguchi U; Hasegawa T
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1340-5. PubMed ID: 15446553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
    Fkih M'hamed I; Privat M; Ponelle F; Penault-Llorca F; Kenani A; Bignon YJ
    Cell Oncol (Dordr); 2015 Dec; 38(6):433-42. PubMed ID: 26392359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The oncomir face of microRNA-206: A permanent miR-206 transfection study.
    Mihály D; Papp G; Mervai Z; Reszegi A; Tátrai P; Szalóki G; Sápi J; Sápi Z
    Exp Biol Med (Maywood); 2018 Aug; 243(12):1014-1023. PubMed ID: 30111166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.